Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	940.61	41.35	-3.97
Graham Fair Price	-61.19	2329.32	6001.43
PEG	-347561.93	-0.06	< 0.005
Price/Book	2.15	1.07	1.05
Price/Cash Flow	85.34	-15.56	-106.16
Prices/Earnings	624.62	7.22	-1.00
Price/Sales	-46.51	16.11	30.11
Price/FCF	85.34	-15.56	-106.16
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-90.00	0.59	-5.89
Operating Margin	-95.17	0.40	-8.19
ROA	-85.80	0.03	-0.19
ROE	-0.26	0.04	-85.90
ROIC	-0.25	0.02	-89.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.09	-80.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-19.86	1.10	-94.49
EPS QOQ	-549.70	1.15	-99.79
FCF QOQ	-1.50	-6.20	-312.28
Revenue QOQ	-0.70	0.97	39.78
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	37.30	377.25	911.45
Days Sales Outstanding (DSO)	171.02	137.15	-19.81
Inventory Turnover	2.41	0.24	-90.11
Debt/Capitalization	0.17	0.16	-3.85
Quick Ratio	1.61	1.38	-14.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2463.35	2546.41	3.37
Cash	1008.71	753.87	-25.26
Capex	-19.20	-159.40	-730.11
Free Cash Flow	-24.40	-175.75	-620.35
Revenue	86.00	169.77	97.40
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.16	1.92	-11.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.27	3.98	1369.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating